EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

HLA-B*44 is associated with a more than twentyfold increase in cyclic citrullinated peptide antibody serum level in Croatian patients with seropositive rheumatoid arthritis

Jure Aljinović iD, Darko Kero iD, Daniela Šošo, Marin Petrić, Daniela Marasović Krstulović, Dijana Perković, Esma Čečuk-Jeličić, Sonja Jaman, Dora Dujmović, Ivanka Marinović

PLOS One · 2025

DOI: 10.1371/journal.pone.0334551 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Jure Aljinović und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Physical Medicine and Rehabilitation with Rheumatology, University Hospital of Split, Split, Croatia. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Peptides, Cyclic, Anti-Citrullinated Protein Antibodies, HLA-B Antigens. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To determine whether any of the HLA-A*, HLA-B* and HLA-DR* alleles in seropositive rheumatoid arthritis (RA) can be associated with the extreme serum levels of rheumatoid factor (RF) and cyclic citrullinated peptide antibodies (anti-CCP).

Methods

This was a retrospective cross-sectional study of adult patients. Demographic data, HLA typing data and RF and anti-CCP levels were collected and analysed.

Results

HLA-A*02, HLA-B*44 and HLA-DRB1*04 were more prevalent in patients from the RA cohort compared to healthy controls. Intra-cohort analysis revealed that HLA-B*44 had an increased frequency of a twenty-fold increase in anti-CCP (P = 0.033) and HLA-A*03 had a borderline (P = 0.063) frequency. HLA-A*03 was more frequent in the groups with >3-fold and >10-fold anti-CCP levels, while HLA-DRB1*04 was of borderline significance at >3-fold anti-CCP increase (P = 0.053). HLA-B*08 showed a lower frequency of 3-, 10- and 20-fold increase in anti-CCP serum levels. Carriers of B*44 (OR = 5.58; P = 0.030), DRB1*04 (OR = 3.89; P = 0.027) or A*03 (OR = 2.71; P = 0.023) were statistically significantly more likely to have a 20-fold increase in anti-CCP levels over the diagnostic threshold. None of the alleles increased the likelihood of having high or extreme RF levels.

Conclusions

HLA-B*44 is associated with a twenty-fold increase in anti-CCP serum levels. HLA-A*03 and HLA-DRB1*04 have a positive trend towards a twenty-fold increase in anti-CCP levels. Earlier aggressive therapy in these patients can prevent such an extreme increase in antibody levels.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidPeptides, CyclicAnti-Citrullinated Protein AntibodiesHLA-B AntigensAutoantibodiesHumansFemaleMaleMiddle AgedAdultCross-Sectional StudiesCroatiaRheumatoid FactorRetrospective StudiesAgedHLA-DRB1 ChainsAlleles

Substanzen

Peptides, Cycliccyclic citrullinated peptideAnti-Citrullinated Protein AntibodiesRheumatoid FactorHLA-B AntigensAutoantibodiesHLA-DRB1 Chains

Autor:innen und Institutionen

  • Division of Physical Medicine and Rehabilitation with Rheumatology, University Hospital of Split, Split, Croatia.
  • University of Split School of Medicine, Split, Croatia.
  • Faculty of Health Sciences, University of Split, Split, Croatia.
  • Study Program of Dental Medicine, University of Split School of Medicine, Croatia.
  • Department of Internal Medicine, Division of Rheumatology, Allergology and Clinical Immunology, University Hospital of Split, Croatia.
  • Division of Transfusion Medicine, University Hospital of Split, Croatia.

ORCID-Profile: Jure Aljinović, Darko Kero

Zitieren

APA

Aljinović, J., Kero, D., Šošo, D., Petrić, M., Marasović Krstulović, D., Perković, D., Čečuk-Jeličić, E., Jaman, S., Dujmović, D., & Marinović, I. (2025). HLA-B*44 is associated with a more than twentyfold increase in cyclic citrullinated peptide antibody serum level in Croatian patients with seropositive rheumatoid arthritis. PLOS One. https://doi.org/10.1371/journal.pone.0334551

Vancouver

Aljinović J, Kero D, Šošo D, Petrić M, Marasović Krstulović D, Perković D, et al. HLA-B*44 is associated with a more than twentyfold increase in cyclic citrullinated peptide antibody serum level in Croatian patients with seropositive rheumatoid arthritis. PLOS One. 2025. doi:10.1371/journal.pone.0334551

BibTeX
@article{Aljinovi2025,
  author = {Aljinović, Jure and Kero, Darko and Šošo, Daniela and Petrić, Marin and Marasović Krstulović, Daniela and Perković, Dijana and Čečuk-Jeličić, Esma and Jaman, Sonja and Dujmović, Dora and Marinović, Ivanka},
  title = {HLA-B*44 is associated with a more than twentyfold increase in cyclic citrullinated peptide antibody serum level in Croatian patients with seropositive rheumatoid arthritis},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0334551}
}
Kostenlos starten →